• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性阿尔茨海默病大鼠模型中中枢肠促胰岛素受体抑制的不同效应。

Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease.

机构信息

Department of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Croatian Institute for Brain Research, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

出版信息

Int J Mol Sci. 2022 Jan 4;23(1):548. doi: 10.3390/ijms23010548.

DOI:10.3390/ijms23010548
PMID:35008973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8745186/
Abstract

The incretin system is an emerging new field that might provide valuable contributions to the research of both the pathophysiology and therapeutic strategies in the treatment of diabetes, obesity, and neurodegenerative disorders. This study aimed to explore the roles of central glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) on cell metabolism and energy in the brain, as well as on the levels of these incretins, insulin, and glucose via inhibition of the central incretin receptors following intracerebroventricular administration of the respective antagonists in healthy rats and a streptozotocin-induced rat model of sporadic Alzheimer's disease (sAD). Chemical ablation of the central GIP receptor (GIPR) or GLP-1 receptor (GLP-1R) in healthy and diseased animals indicated a region-dependent role of incretins in brain cell energy and metabolism and central incretin-dependent modulation of peripheral hormone secretion, markedly after GIPR inhibition, as well as a dysregulation of the GLP-1 system in experimental sAD.

摘要

肠促胰岛素系统是一个新兴的领域,可能为糖尿病、肥胖症和神经退行性疾病的病理生理学和治疗策略的研究提供有价值的贡献。本研究旨在探讨中枢胰高血糖素样肽-1(GLP-1)和胃抑制多肽(GIP)对大脑细胞代谢和能量的作用,以及通过向健康大鼠和链脲佐菌素诱导的散发性阿尔茨海默病(sAD)大鼠模型的侧脑室给予相应拮抗剂抑制中枢肠促胰岛素受体后,这些肠促胰岛素、胰岛素和葡萄糖的水平。化学消融健康和患病动物的中枢 GIP 受体(GIPR)或 GLP-1 受体(GLP-1R)表明,肠促胰岛素在脑细胞能量和代谢中具有区域依赖性作用,并且中枢肠促胰岛素依赖性调节外周激素分泌,在 GIPR 抑制后更为明显,以及实验性 sAD 中 GLP-1 系统的失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/69c522c0ac69/ijms-23-00548-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/263ca557ec11/ijms-23-00548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/6adb01a2e37b/ijms-23-00548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/5fc1812e3b43/ijms-23-00548-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/affa359a15c1/ijms-23-00548-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/1433564a4060/ijms-23-00548-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/69c522c0ac69/ijms-23-00548-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/263ca557ec11/ijms-23-00548-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/6adb01a2e37b/ijms-23-00548-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/5fc1812e3b43/ijms-23-00548-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/affa359a15c1/ijms-23-00548-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/1433564a4060/ijms-23-00548-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fad/8745186/69c522c0ac69/ijms-23-00548-g006.jpg

相似文献

1
Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer's Disease.散发性阿尔茨海默病大鼠模型中中枢肠促胰岛素受体抑制的不同效应。
Int J Mol Sci. 2022 Jan 4;23(1):548. doi: 10.3390/ijms23010548.
2
Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors.肠促胰岛素激素调节小胶质细胞氧化应激、存活和营养因子的表达。
Eur J Cell Biol. 2017 May;96(3):240-253. doi: 10.1016/j.ejcb.2017.03.004. Epub 2017 Mar 8.
3
Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.基于双重肠促胰岛素受体激活的糖尿病和肥胖治疗:“双激素”。
Diabetes Obes Metab. 2016 Sep;18(9):847-54. doi: 10.1111/dom.12685. Epub 2016 Jun 7.
4
Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.胰高血糖素样肽 1 和葡萄糖依赖性胰岛素释放肽刺激 TRPV1 和 TRPA1 表达的感觉神经释放 P 物质。
Am J Physiol Gastrointest Liver Physiol. 2020 Jul 1;319(1):G23-G35. doi: 10.1152/ajpgi.00189.2019. Epub 2020 May 18.
5
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.两种肠促胰岛素激素 GLP-1 和 GIP:比较它们在胰岛素分泌和β细胞保护中的作用。
Prog Biophys Mol Biol. 2011 Nov;107(2):248-56. doi: 10.1016/j.pbiomolbio.2011.07.010. Epub 2011 Jul 28.
6
Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism.胃抑制肽、胰高血糖素样肽-1 和胰高血糖素样肽-1 受体激动剂对骨细胞代谢的影响。
Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):25-37. doi: 10.1111/bcpt.12850. Epub 2017 Aug 11.
7
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.作为肠促胰岛素激素的葡萄糖依赖性促胰岛素多肽(GIP)和胰高血糖素样肽-1(GLP-1):来自单和双肠促胰岛素受体敲除小鼠的经验教训。
Regul Pept. 2005 Jun 15;128(2):125-34. doi: 10.1016/j.regpep.2004.07.019.
8
Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.埃及患者肠促胰岛素受体基因多态性与 2 型糖尿病的相关性。
J Gene Med. 2017 Sep;19(9-10). doi: 10.1002/jgm.2973. Epub 2017 Sep 21.
9
Incretin actions beyond the pancreas: lessons from knockout mice.肠促胰岛素作用超出胰腺:敲除小鼠的启示。
Curr Opin Pharmacol. 2013 Dec;13(6):946-53. doi: 10.1016/j.coph.2013.09.013. Epub 2013 Oct 4.
10
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.针对肥胖的 GIPR 靶点:激动还是拮抗?潜在机制。
Mol Metab. 2021 Apr;46:101139. doi: 10.1016/j.molmet.2020.101139. Epub 2020 Dec 5.

引用本文的文献

1
Species-specific sensitivity to intracerebroventricular streptozotocin in rats and mice highlights pathways and proteins relevant to Alzheimer's disease.大鼠和小鼠对脑室内注射链脲佐菌素的种属特异性敏感性突出了与阿尔茨海默病相关的途径和蛋白质。
J Neural Transm (Vienna). 2025 Jun 1. doi: 10.1007/s00702-025-02952-w.
2
The Effect of the Sodium-Glucose Cotransporter Inhibitor on Cognition and Metabolic Parameters in a Rat Model of Sporadic Alzheimer's Disease.钠-葡萄糖协同转运蛋白抑制剂对散发性阿尔茨海默病大鼠模型认知及代谢参数的影响
Biomedicines. 2023 Mar 27;11(4):1025. doi: 10.3390/biomedicines11041025.
3
Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson's Disease.

本文引用的文献

1
Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer's Disease.在散发性阿尔茨海默病大鼠模型中,脑胰高血糖素样肽-1介导的肠道氧化还原稳态调控功能障碍
Antioxidants (Basel). 2021 Jul 13;10(7):1118. doi: 10.3390/antiox10071118.
2
GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease.GLP-1 通过促进阿尔茨海默病中的有氧糖酵解来提高星形胶质细胞对神经元的支持能力。
Mol Metab. 2021 May;47:101180. doi: 10.1016/j.molmet.2021.101180. Epub 2021 Feb 6.
3
Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease.
帕金森病大鼠模型中认知缺陷与谷氨酸和胰岛素信号传导的关联
Biomedicines. 2023 Feb 23;11(3):683. doi: 10.3390/biomedicines11030683.
4
Probing the E1o-E2o and E1a-E2o Interactions in Binary Subcomplexes of the Human 2-Oxoglutarate Dehydrogenase and 2-Oxoadipate Dehydrogenase Complexes by Chemical Cross-Linking Mass Spectrometry and Molecular Dynamics Simulation.通过化学交联质谱和分子动力学模拟探测人 2-氧戊二酸脱氢酶和 2-氧代戊二酸脱氢酶复合物的二元亚复合物中的 E1o-E2o 和 E1a-E2o 相互作用。
Int J Mol Sci. 2023 Feb 25;24(5):4555. doi: 10.3390/ijms24054555.
利拉鲁肽在链脲佐菌素诱导和 5xFAD 阿尔茨海默病小鼠模型中具有抗炎和抗淀粉样蛋白特性。
Int J Mol Sci. 2021 Jan 16;22(2):860. doi: 10.3390/ijms22020860.
4
Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice.线粒体复合物I的部分抑制改善了APP/PS1雌性小鼠的阿尔茨海默病病理和认知功能。
Commun Biol. 2021 Jan 8;4(1):61. doi: 10.1038/s42003-020-01584-y.
5
Metabolic Dysregulation Contributes to the Progression of Alzheimer's Disease.代谢失调促进阿尔茨海默病的进展。
Front Neurosci. 2020 Nov 5;14:530219. doi: 10.3389/fnins.2020.530219. eCollection 2020.
6
Repurposing GLP1 agonists for neurodegenerative diseases.将 GLP1 激动剂重新用于神经退行性疾病。
Int Rev Neurobiol. 2020;155:91-112. doi: 10.1016/bs.irn.2020.02.007. Epub 2020 Aug 11.
7
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches.阿尔茨海默病及相关疾病中的脑胰岛素抵抗:机制与治疗方法。
Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27.
8
Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.肠激素 GIP 可引起下丘脑炎症和胰岛素抵抗。
Endocrinology. 2020 Sep 1;161(9). doi: 10.1210/endocr/bqaa102.
9
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.健康个体进餐后的 GIP 和 GLP-1 受体拮抗作用。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz175.
10
The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.新型 GLP-1/GIP 类似物 DA5-CH 可降低 AD 模型大鼠 icv 中的 tau 磷酸化并使 theta 节律正常化。
Brain Behav. 2020 Mar;10(3):e01505. doi: 10.1002/brb3.1505. Epub 2020 Jan 20.